A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency

European Journal of Endocrinology

Volumn 144, Issue 1, 2001, Pages 13-20

  Schonau E ^a   Westermann, F ^a   Rauch, F ^a   Stabrey, A ^a   Wassmer, G ^a   Keller, E ^a   Bramswig J ^a   Blum, W F ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYPYRIDINOLINE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ARTICLE; BODY HEIGHT; BODY MASS; BONE AGE; BONE METABOLISM; CHILD; CLINICAL TRIAL; FEMALE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OSTEOLYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME;

EID: 0035153845     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1440013     Document Type: Article

References (24)

1. Should we treat children with idiopathic short stature?
2. Prediction of the growth response in children with various growth disorders treated with growth hormone: Analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study
3. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. FIGS International Board. Kabi Pharmacia International Growth Study
4. Prediction of the outcome of growth hormone therapy in children with idiopathic short stature. A multivariate discriminant analysis
5. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment
6. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age
7. Growth parameters and predictors of growth in short children with and without growth hormone (GH) deficiency treated with human GH: A randomized controlled study
8. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency
9. Predictors of growth response to growth hormone in otherwise normal short children
10. Prediction of the growth response of short prepubertal children treated with growth hormone. Swedish Paediatric Study Group for GH treatment
11. Short-term changes in serum leptin levels provide a strong metabolic marker for the growth response to growth hormone treatment in children. Swedish Study Group for Growth Hormone Treatment
12. Bone alkaline phosphatase and height velocity in short normal children undergoing growth-promoting treatments: Longitudinal study
13. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen
14. Serum aminoterminal propeptide of type III procollagen: A potential predictor of the response to growth hormone therapy
15. The growth rate of healthy children in the first 16 years: Bonn-Dortmund longitudinal developmental study
16. Tables for predicting adult height from skeletal age: Revised for use with the Greulich-Pyle hand standards
17. Radioimmunoassays for IGFs and IGFBPs
18. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency
19. Can we measure growth?
20. Bone-forming cells in clinical conditions
21. Collagen metabolites in the prediction of response to GH therapy in short children
22. Serum procollagen I carboxyterminal propeptide (PICP) levels through puberty: Relation to height velocity and serum hormone levels
23. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group
24. Final height after long-term growth hormone treatment in Turner syndrome. European Study Group